
Ontozry — cenobamate 200 mg, film-coated tablets, 28 pcs
Brand: Angelini Pharma
+ delivery from €40
Ontozry. Active ingredient: cenobamate, 200 mg. Dosage form — film-coated tablets. Pack size: 28 tablets of 200 mg.
Key information
Full description
Ontozry 200 mg is a medicine from Angelini Pharma S.p.A., Italy, containing cenobamate. It is available as oval, light orange film-coated tablets marked "AV" and "200". Cenobamate is an antiepileptic medicine intended for the treatment of partial-onset seizures in adults as part of therapy prescribed by a doctor. The pack contains 28 tablets of 200 mg. The medicine contains lactose and is subject to additional safety monitoring. Treatment is started at a low dose and increased gradually according to the doctor's regimen; read the official package leaflet before use.
Administration
For oral use. The dosing regimen and duration of use are determined by the doctor, taking into account the official package leaflet.
Storage conditions
Store in the original package under the conditions specified by the manufacturer in the official package leaflet. Keep out of the reach of children.
Frequently asked questions
What active ingredient does Ontozry contain?
Ontozry contains cenobamate.
What dosage form is Ontozry available in?
Dosage form: Film-coated tablets. Strength: 200 mg.
How much medicine is in an Ontozry pack?
The pack shown contains 28 tablets of 200 mg.
How should Ontozry be stored?
Store in the original package under the conditions specified by the manufacturer in the official package leaflet. Keep out of the reach of children.
Other strengths and pack sizes
Alternatives with the same active ingredient
Medicines with the same active ingredient may differ in excipients. Switching is only possible with your doctor's approval.
How to order
Tap the button for your preferred messenger. A manager will check availability, confirm the price and ask for your full delivery address.
This information is for reference only. Consult a doctor and read the official package leaflet before use.